Mizacorat

Mizacorat (AZD9567) is an investigational selective glucocorticoid receptor modulator that has a better ratio of therapeutic effect to adverse effects compared to prednisolone according to preliminary studies. It is developed by AstraZeneca for rheumatoid arthritis.